We work hard to attract, retain, and support the most outstanding faculty.

TO REMOVE

The Relationship of Kidney Tubule Biomarkers with Brain Imaging in CKD Patients in SPRINT.

2021

Authors: Miller LM, Kurella Tamura M, Pajewski NM, Rifkin D, Weiner D, Marquine M, Shlipak MG, Ix JH

TO REMOVE

The Reproductive Transition: Effects on Viral Replication, Immune Activation, and Metabolism in Women with HIV infection.

2021

Authors: Abelman R, Tien PC

Frontiers in physiology

Computational Modelling of Glucose Uptake by SGLT1 and Apical GLUT2 in the Enterocyte.

2021

Authors: Afshar N, Safaei S, Nickerson DP, Hunter PJ, Suresh V

TO REMOVE

The Next Frontier of Less Is More-From Description to Implementation.

2021

Authors: Latifi N, Redberg RF, Grady D

Open forum infectious diseases

Safety and Efficacy of Tocilizumab 4 or 8 mg/kg in Hospitalized Patients With Moderate to Severe Coronavirus Disease 2019 Pneumonia: A Randomized Clinical Trial.

2021

Authors: Kumar PN, Hernández-Sánchez J, Nagel S, Feng Y, Cai F, Rabin J, Morse CG, Nadig NR, Ashraf O, Gotur DB, McComsey GA, Gafoor K, Perin P, Thornton SC, Stubbings W, Lin CJF, Tsai L

JAMA health forum

Coverage, Formulary Restrictions, and Affordability of Sodium-Glucose Cotransporter 2 Inhibitors by US Insurance Plan Types.

2021

Authors: Sri Lekha Tummalapalli, Julio Lamprea Montealegre, Neil Warnock, Michael Green, Said A. Ibrahim, Michelle M. Estrella

"HIV within the House Ball Community and the Promise of Community-based Social Structures for Intervention and Support"

Colonoscopy utilization and outcomes in older adults: Data from the New Hampshire Colonoscopy Registry.

2021

Authors: Calderwood AH, Tosteson TD, Walter LC, Hua P, Onega T

"HIV within the House Ball Community and the Promise of Community-based Social Structures for Intervention and Support"

Predictors of Regret Among Older Men After Stress Urinary Incontinence Treatment Decisions.

2021

Authors: Hampson LA, Suskind AM, Breyer BN, Cooperberg MR, Sudore RL, Keyhani S, Allen IE, Walter LC

TO REMOVE

Tolérance et efficacité à long terme du bimékizumab chez les patients atteints de spondylarthrite ankylosante : résultats à 3 ans d’une étude de phase IIb.

2021

Authors: D. Van Der Heijde, A. Deodhar, L. Gensler, D. Poddubnyy, A. Kivitz, M. Dougados, N. De Peyrecave, M. Oortgiesen, T. Vaux, C. Fleurinck, X. Baraliakos

TO REMOVE

Poursuite ou arrêt du traitement par l’ixékizumab chez des patients atteints de spondyloarthrite axiale et ayant atteint la rémission : résultats d’une étude de retrait randomisé, contrôlée versus placebo.

2021

Authors: R. Landewé, L. Gensler, D. Poddubnyy, P. Rahman, M. Hojnik, X. Li, S. Liu-Leage, D. Adams, H. Carlier, F. Van den Bosch, C. Lukas